CIK 0001401914 · Non-accelerated filer<br>Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 204139823
- Phone
- 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- 4 Open-market buy Director bought 8,900 shares at an average $2.43 ($21,660)
- 4 Open-market buy Director bought 8,572 shares at an average $2.53 ($21,711)
- 4 Open-market buy Director bought 8,684 shares at an average $2.79 ($24,209)
- 4 Open-market buy Director bought 8,855 shares at an average $2.87 ($25,408)
- 4 Open-market buy Director bought 8,800 shares at an average $2.95 ($25,985)
- 4 Grant or award Chief Executive Officer acquired 2,757 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 8,801 shares at an average $3.03 ($26,691)
- 4 Open-market buy Director bought 10,000 shares at $3.75 ($37,488)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,374 shares at $3.25 ($17,460)
- 4 Open-market buy Director bought 12,117 shares at an average $3.32 ($40,197)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
Page 32 of 39 · 778 filings